Single dose ofloxacin in the eradication of pharyngeal carriage of Neisseria meningitidis.
Halstensen
A
A
Medical Department B, University of Bergen, Norway.
Gilja
O H
OH
Digranes
A
A
Mylvaganam
H
H
Aksnes
A
A
Høiby
E A
EA
Rolstad
T
T
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy*; D016172:DNA Fingerprinting; D005260:Female; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D009345:Neisseria meningitidis / Q000187:drug effects*; D015242:Ofloxacin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010614:Pharynx / Q000187:drug effects / Q000382:microbiology*
D000890:Anti-Infective Agents; D015242:Ofloxacin